Abstract
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is induced by mutations in triadin or calsequestrin. Deletion/mutation of triadin is associated with reduction in calsequestrin and leads to CPVT. Cacheux and colleagues show that partial re-expression of triadin and calsequestrin through gene or pharmacological therapy reverses this cardiac arrhythmia.
Original language | English |
---|---|
Pages (from-to) | 171-179 |
Number of pages | 9 |
Journal | Molecular Therapy |
Volume | 28 |
Issue number | 1 |
DOIs | |
State | Published - 8 Jan 2020 |
Externally published | Yes |
Keywords
- Ca release
- cardiac arrhythmia
- gene therapy
- genetic disease
- sarcoplasmic reticulum